Patents by Inventor Henry Chiou

Henry Chiou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11498949
    Abstract: High-yield mammalian transient expression systems can include a cell culture media (particularly serum free, non-animal derived, and/or chemically defined media) for introducing macromolecules and compounds (e.g., nucleic acid molecules) into cells (e.g., eukaryotic cells). Cells containing such introduced materials can then be cultured in the cell culture media. In particular, the invention allows introduction of nucleic acid molecules (e.g., vectors) into cells (particularly mammalian cells) and expression of proteins encoded by the nucleic acid molecules in the cells. The invention obviates the need to change the cell culture medium each time a different procedure is performed with the cells (e.g., culturing cells vs. transfecting cells). The invention also relates to compositions and kits useful for culturing and transforming/transfecting cells.
    Type: Grant
    Filed: July 26, 2018
    Date of Patent: November 15, 2022
    Assignee: LIFE TECHNOLOGIES CORPORATION
    Inventors: Sanjay Vasu, Chao Yan Liu, Jeffrey Rogers, Maria Cisneros, Jingqiu Li, Henry Chiou, Meredith Jones
  • Publication number: 20190077841
    Abstract: High-yield mammalian transient expression systems can include a cell culture media (particularly serum free, non-animal derived, and/or chemically defined media) for introducing macromolecules and compounds (e.g., nucleic acid molecules) into cells (e.g., eukaryotic cells). Cells containing such introduced materials can then be cultured in the cell culture media. In particular, the invention allows introduction of nucleic acid molecules (e.g., vectors) into cells (particularly mammalian cells) and expression of proteins encoded by the nucleic acid molecules in the cells. The invention obviates the need to change the cell culture medium each time a different procedure is performed with the cells (e.g., culturing cells vs. transfecting cells). The invention also relates to compositions and kits useful for culturing and transforming/transfecting cells.
    Type: Application
    Filed: July 26, 2018
    Publication date: March 14, 2019
    Inventors: Sanjay VASU, Chao Yan LIU, Jeffrey ROGERS, Maria CISNEROS, Jingqiu LI, Henry CHIOU, Meredith JONES
  • Patent number: 10066000
    Abstract: High-Yield mammalian transient expression systems can include a cell culture media (particularly serum free, non animal derived, and/or chemically defined media) for introducing macromolecules and compounds (e.g., nucleic acid molecules) into cells (e.g., eukaryotic cells). Cells containing such introduced materials can then be cultured in the cell culture media. In particular, the invention allows introduction of nucleic acid molecules (e.g., vectors) into cells (particularly mammalian cells) and expression of proteins encoded by the nucleic acid molecules in the cells. The invention obviates the need to change the cell culture medium each time a different procedure is performed with the cells (e.g., culturing cells vs. transfecting cells). The invention also relates to compositions and kits useful for culturing and transforming/transfecting cells.
    Type: Grant
    Filed: May 2, 2013
    Date of Patent: September 4, 2018
    Assignee: Life Technologies Corporation
    Inventors: Sanjay Vasu, Henry Chiou, Jeffrey Rogers, Maria Isabel Cisneros, Jingqiu Li, Chao Yan Liu, Meredith Jones
  • Publication number: 20130316400
    Abstract: The present invention is directed generally to cell culture media (particularly serum free, non animal derived, and/or chemically defined media) which are useful for introducing macromolecules and compounds (e.g., nucleic acid molecules) into cells (e.g., eukaryotic cells). According to the invention, such introduction can take place in the presence of said medium. Cells containing such introduced materials can then be cultured in the medium and the effect of the introduced materials on the cells can be measured or determined. In particular, the invention allows introduction of nucleic acid molecules (e.g., vectors) into cells (particularly eukaryotic cells) and expression of proteins encoded by the nucleic acid molecules in the cells. The invention obviates the need to change the cell culture medium each time a different procedure is performed with the cells (e.g., culturing cells vs. transfecting cells).
    Type: Application
    Filed: May 2, 2013
    Publication date: November 28, 2013
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: Sanjay VASU, Henry CHIOU, Jeffrey ROGERS, Maria Isabel CISNEROS, Jingqiu LI, Chao Yan LIU, Meredith JONES
  • Publication number: 20060257858
    Abstract: The invention relates to methods for introducing target biopolymers (e.g., nucleic acid molecules, proteins, etc.) and other compounds (e.g., non-polymeric organic molecules, such as steroids) into cells (e.g., eukaryotic cells). The invention further relates to compositions comprising target biopolymers and other compounds. In certain aspects, the invention relates to the deposition of target biopolymer-containing mixtures onto surfaces optionally followed by contacting these target biopolymer-containing mixtures with cells (e.g., eukaryotic cells). Additionally, when the target biopolymers are nucleic acid molecules, expression of these nucleic acid molecules by cells which are contacted with the target biopolymers may be monitored or detected.
    Type: Application
    Filed: March 31, 2006
    Publication date: November 16, 2006
    Applicant: INVITROGEN CORPORATION
    Inventors: Henry Chiou, Alfred Sundquist, Weixing Chen, Paul Cizdiel
  • Publication number: 20060228406
    Abstract: The present invention discloses liposomal transfection reagents for delivery of macromolecules and other compounds into cells, particularly non-adherent suspension cells. They are especially useful for the DNA-dependent transformation of cells. Methods for their preparation and use as intracellular delivery agents are also disclosed.
    Type: Application
    Filed: March 17, 2006
    Publication date: October 12, 2006
    Applicant: Invitrogen Corporation
    Inventors: Henry Chiou, Charles Shevlin